Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease

Low high-density lipoprotein-cholesterol (HDL-c) is the most remarkable lipid trait both in mild-to-moderate chronic kidney disease (CKD) patients as well as in advanced renal disease stages, and we have previously shown that reduced lecithin:cholesterol acyltransferase (LCAT) concentration is a maj...

Descripción completa

Detalles Bibliográficos
Autores principales: Baragetti, Andrea, Ossoli, Alice, Strazzella, Arianna, Simonelli, Sara, Baragetti, Ivano, Grigore, Liliana, Pellegatta, Fabio, Catapano, Alberico L., Norata, Giuseppe Danilo, Calabresi, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408930/
https://www.ncbi.nlm.nih.gov/pubmed/32708515
http://dx.doi.org/10.3390/jcm9072289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408930/
https://www.ncbi.nlm.nih.gov/pubmed/32708515
http://dx.doi.org/10.3390/jcm9072289

Ejemplares similares